Candidiasis
Introduction
Candidiasis is a common opportunistic fungal infection caused by yeasts of the genus Candida, primarily Candida albicans. These fungi are typically part of the normal human microbiota, residing harmlessly on skin and mucous membranes. However, under certain conditions, such as a weakened immune system, disruption of the normal microbial flora, or changes in host physiology, Candida can overgrow and cause infection. [1]
Biological Basis
The ability of Candida species to cause disease is influenced by various virulence factors, including their capacity to adhere to host tissues, form biofilms, and secrete enzymes that damage host cells. Host genetic factors are recognized as playing a critical role in an individual's susceptibility to infections, including candidiasis. [1] Research into the genetic underpinnings of infection susceptibility has revealed high heritability for such traits, indicating a significant inherited component to how individuals respond to pathogens. [1]
Recent genome-wide association studies (GWAS) and transcriptome-wide association studies (TWAS) have begun to identify specific genetic regions and gene expression patterns associated with the risk of candidiasis. For instance, associations have been observed between candidiasis risk and the WDR88/LRP3 gene region. [1] The LRP3 gene, encoding LDL receptor related protein 3, is involved in the internalization of lipophilic molecules, and its genetically predicted increased expression in various tissues, including esophageal mucosa (a known site of Candida infection), has been linked to an elevated risk of candidiasis. [1] Similarly, genetically predicted increased expression of WDR88 (WD repeat-containing protein 88) in tissues like the liver and brain cortex has also been associated with an altered risk of candidiasis. [1] The T allele of rs10422015 in WDR88 has been specifically associated with an increased risk of candidiasis. [1] The ABO gene region has also shown an association with candidiasis. [1] The consistent observation of these associations across multiple tissues suggests common underlying biological mechanisms influencing susceptibility to candidiasis. [1]
Clinical Relevance
Candidiasis manifests in a wide spectrum of clinical presentations, ranging from superficial infections of the skin, mouth (oral thrush), and vagina (vulvovaginal candidiasis) to severe, life-threatening systemic infections, particularly in immunocompromised individuals. Systemic candidiasis, or candidemia, can lead to significant morbidity and mortality, making its understanding and management crucial in clinical practice. [1] The average age of individuals diagnosed with candidiasis in some studies has been reported as approximately 51.2 years, indicating its prevalence across adult populations. [1]
Social Importance
The widespread occurrence of candidiasis, from common "yeast infections" affecting quality of life to severe invasive forms with high mortality rates, underscores its substantial social and economic impact. Effective diagnosis, treatment with antifungal medications, and preventive strategies are vital to reduce the burden of this infection on individuals and healthcare systems globally.
Methodological and Statistical Constraints
The study faced several methodological and statistical limitations that could influence the interpretation of findings for candidiasis. A significant challenge was the statistical power for replication, as the study had less than 50% power to detect the odds ratios reported in prior research for candidiasis, which complicates the validation of previous associations. [1] Furthermore, the reliance on single-SNP predictions in transcriptome-wide association studies (TWAS) may offer less robust insights into gene expression compared to models incorporating multiple variants, although the authors note instances where single SNPs are significant and observed associations across multiple tissues. [1] The potential for misclassification of controls also exists, as the matched control population might inadvertently be enriched for unmeasured co-segregating factors related to infections, which could subtly bias the observed associations. [1]
Generalizability and Phenotype Ascertainment Challenges
A notable limitation is the restricted generalizability of the findings due to the study population's demographic characteristics. The research was primarily conducted in White patients, and the sample sizes for Black patients were often too small for robust genome-wide association studies (GWAS) for many infections, including potentially candidiasis, thus limiting the applicability of results to diverse populations. [1] The use of ICD codes for phenotype ascertainment, while practical for large biobanks, poses challenges as these codes are primarily for billing rather than research, potentially leading to misclassification or inconsistent coding of conditions. [1] This contrasts with other studies that might use self-reported data or different diagnostic criteria, contributing to discrepancies in findings and impacting the sensitivity and specificity of disease definitions. [1] The nature of a hospital-based biobank also means the cohort predominantly consists of individuals with documented medical conditions, potentially limiting insights into healthier populations. [2]
Unaccounted Environmental Factors and Mechanistic Gaps
The current analysis did not account for critical environmental, social, and economic factors that are known to vary across populations and significantly influence infection susceptibility. [1] The omission of these potentially important covariates means that the observed genetic associations might be confounded or their full impact not accurately captured, representing a portion of the "missing heritability" for infectious diseases. [1] Moreover, while novel genetic associations for candidiasis were identified, such as with the WDR88 and LRP3 genes, the precise biological mechanisms through which these genes influence candidiasis risk remain largely unclear. [1] Further research is needed to elucidate the functional roles of these genes and how they contribute to host response against Candida infections.
Variants
The rs10422015 variant and its associated gene, WDR88 (WD repeat-containing protein 88), are significantly linked to an increased risk of candidiasis, a common fungal infection. The WDR88 gene encodes a protein characterized by WD40 repeats, which are common structural motifs found in a wide range of eukaryotic proteins. These WD repeat domains typically facilitate protein-protein interactions, acting as scaffolds for the assembly of multiprotein complexes involved in diverse cellular functions such as signal transduction, cell cycle progression, and transcriptional regulation. [1] Although the precise function of WDR88 in human health remains largely undefined, studies indicate that genetically predicted increased expression of WDR88 in tissues like the liver and brain cortex is significantly associated with an elevated susceptibility to candidiasis. [1] This association suggests a potential, yet to be fully elucidated, role for WDR88 in the body's immune response or susceptibility pathways to fungal infections, with the association observed in multiple tissues implying common underlying mechanisms.
Specifically, the T allele of rs10422015 has been identified as a significant genetic factor contributing to an increased risk of candidiasis, with an odds ratio of 1.31. [1] This single nucleotide polymorphism (SNP) is located within the WDR88 gene region, and its influence on candidiasis risk appears to be mediated, at least in part, through its effect on WDR88 gene expression. Beyond candidiasis, rs10422015 has also shown significant associations with other clinical phenotypes, including heel bone mineral density T-score, suggesting broader pleiotropic effects. [1] Furthermore, suggestive links have been observed between rs10422015 and conditions such as cough and postoperative infection, indicating its potential involvement in general immune or inflammatory responses that could influence susceptibility to various health issues.
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs10422015 | WDR88 | candidiasis |
| rs9527992 | RPP40P2 - RNU7-88P | candidiasis |
Defining Candidiasis and its Nomenclature
Candidiasis is a fungal infection caused by yeasts of the Candida genus, most commonly Candida albicans. It is recognized as a common infection, affecting various parts of the body. [1] The terms "candidiasis" and "candida infection" are often used interchangeably to describe this condition. [1] Recent research has explored the genetic underpinnings of susceptibility to candidiasis, identifying specific genetic regions and gene expressions linked to altered risk. For instance, the WDR88/LRP3 region has been associated with the risk of candidiasis, and genetically determined expression of WDR88 and LRP3 in various tissues shows an association with altered risk. [1] Furthermore, rs10422015 has been identified as a lead GWAS hit for candidiasis, suggesting its potential role as a genetic marker. [1]
Classification Systems and Clinical Presentation
Candidiasis is broadly classified as an infectious disease, with its specific manifestations often categorized by the anatomical site affected. The esophagus, for example, is a well-described site for candida infection, indicating a classification by location. [1] In clinical and research settings, standardized nosological systems, such as the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD9CM) and Tenth Revision, Clinical Modification (ICD10CM) codes, are routinely employed to define and classify candidiasis and other infections. [1] While some studies may treat the frequency of candidiasis as a quantitative trait, research often approaches it as a categorical or binary trait, distinguishing between individuals who are cases and those who are controls. [1] This categorical approach is particularly common in genome-wide association studies (GWAS) where clear case-control definitions are essential for identifying genetic associations.
Operational Definitions and Diagnostic Criteria in Research
For research purposes, precise operational definitions and diagnostic criteria are crucial for accurately identifying cases of candidiasis. In one study, individuals were categorized as cases if they had two or more ICD codes for candidiasis recorded on different days within their electronic health records. [1] Conversely, individuals with only a single mention of an ICD code related to candidiasis were excluded from the analysis to ensure a robust case definition, while controls were selected from individuals with no ICD codes for the disease. [1] Another research framework utilized PheCode criteria, requiring clinical diagnoses to be established on at least three distinct occasions to define a disease, including infections. [2] These criteria establish clear thresholds for case ascertainment, which are vital for studies investigating genetic associations, such as those linking the expression of genes like LRP3 and WDR88 to candidiasis risk. [1]
Diverse Clinical Manifestations
Candidiasis, an infection caused by Candida species, can manifest with a wide range of clinical presentations affecting multiple organ systems. The esophagus is a well-documented site for Candida infection. [1] Genetic studies indicate associations between candidiasis risk and the genetically predicted expression of genes such as LRP3 in diverse tissues, including esophagus mucosa, brain spinal cord cervical, artery, spleen, prostate, adrenal gland, and minor salivary gland. [1] Similarly, increased expression of WDR88 in the liver and brain cortex has been linked to an altered risk of candidiasis [1] suggesting that the infection's response can affect various organs and lead to a spectrum of clinical phenotypes, from localized to more systemic involvement. A genetic variant, rs10422015, associated with candidiasis, has also shown a suggestive association with cough [1] hinting at potential respiratory or generalized symptomatic involvement in some cases.
Diagnostic Approaches and Phenotypic Classification
The identification of candidiasis in large-scale studies relies on objective diagnostic criteria derived from clinical records. Cases are typically defined by the presence of two or more International Classification of Diseases (ICD) codes for candidiasis recorded on different days. [1] This approach distinguishes active infections from single, potentially incidental, mentions of the code, with individuals having only one ICD code excluded from case status. [1] Similarly, some studies utilize PheCode criteria, requiring relevant ICD codes on at least three distinct occasions to establish a clinical diagnosis. [2] Control groups are established by selecting individuals with no relevant ICD or PheCodes, providing a robust, record-based method for classifying cases and controls, which is critical for large-cohort analyses.
Influencing Factors and Phenotypic Variability
The presentation and prevalence of candidiasis can exhibit significant inter-individual variation influenced by factors such as age and sex. Studies commonly match controls to cases based on age and sex, acknowledging their impact on disease incidence. [1] For candidiasis, the mean age of cases in large biobank studies has been observed around 51.2 years [1] with the general understanding that the incidence of many diseases, including infections, tends to increase with age. [2] It is also recognized that younger individuals may have fewer accumulated clinical diagnoses due to shorter electronic health record (EHR) lengths. [1] Furthermore, genetic predispositions, such as the genetically predicted expression of LRP3 and WDR88 in various tissues, suggest underlying mechanisms that contribute to an individual's susceptibility and the diverse organ involvement observed in candidiasis [1] highlighting the genetic and demographic heterogeneity in its clinical expression.
Genetic Predisposition and Specific Loci
Candidiasis, a common fungal infection, exhibits a significant genetic component influencing an individual's susceptibility. Genome-wide association studies (GWAS) have identified specific genetic regions and variants linked to an altered risk of candidiasis. Notably, an association has been observed between the WDR88/LRP3 region and the risk of developing candidiasis. [1] Further investigation revealed that the T allele of rs10422015, located within the WDR88 gene, is specifically associated with an increased risk of candidiasis. [1]
Beyond these specific loci, the ABO gene region has also been associated with candidiasis, suggesting a broader polygenic influence on an individual's vulnerability to this infection. [1] These findings underscore the role of inherited genetic variants in modulating host defense mechanisms and susceptibility to fungal pathogens. Such genetic predispositions contribute to the variability in how individuals respond to exposure and develop candidiasis.
Molecular Mechanisms of Host Response
The genetic associations observed in candidiasis are further elucidated by their impact on gene expression and molecular function, which can directly influence host susceptibility. Genetically predicted increased expression of the LDL receptor related protein 3 gene (LRP3) and the WDR88 gene has been significantly linked to an elevated risk of candidiasis. [1] LRP3 is known to encode LDL receptor related protein 3, a molecule involved in the internalization of lipophilic substances, and its altered expression may influence how the body processes or responds to components related to the fungal pathogen. [1]
The association of LRP3 expression with candida infection in the esophageal mucosa is particularly noteworthy, given that the esophagus is a well-documented site for candidiasis. [1] These genetically determined expression changes for LRP3 and WDR88 have been observed across various tissues, including the esophagus mucosa, brain spinal cord, artery, spleen, prostate, adrenal gland, minor salivary gland, liver, and brain cortex, suggesting common underlying molecular mechanisms that broadly affect the host's ability to resist or control candida infections across multiple organ systems. [1]
Broader Determinants of Infection Risk
Susceptibility to infections generally, including candidiasis, is recognized to have a substantial heritable component, indicating that genetic factors play a significant role in determining an individual's overall risk. Studies, including large twin analyses, have demonstrated high heritability for various infection-related traits, such as general infection (h2 = 0.43), staphylococcal infection (h2 = 0.7), and even death due to infection (h2 = 0.4). [3] This broad genetic predisposition suggests a complex interplay of many genes, contributing to a polygenic risk profile for infectious diseases. Furthermore, environmental, social, and economic factors are acknowledged as important variables that vary among populations and can influence overall infection risk. [1] While specific mechanisms or interactions between these factors and candidiasis risk were not detailed in the provided research, their general influence on host health, immune function, and exposure pathways is a critical consideration in understanding the complex etiology of infectious diseases.
Genetic Predisposition and Gene Expression Regulation
Candidiasis, a common fungal infection, is influenced by host genetic factors, particularly through the regulation of gene expression. Genome-wide association studies (GWAS) have identified specific genomic regions, such as the WDR88/LRP3 locus, that are significantly associated with an altered risk of candidiasis. [1] Further transcriptome-wide association studies (TWAS) indicate that the genetically determined expression levels of both WDR88 and LRP3 genes in various tissues correlate with an individual's susceptibility to the infection. [1] For instance, the T allele of rs10422015 located within the WDR88 region has been linked to an increased risk of candidiasis, highlighting a specific genetic variant's role in this predisposition. [1] These findings underscore the importance of genetic mechanisms and gene expression patterns in shaping an individual's defense against candidal infections.
Key Molecular Players and Cellular Functions
At the molecular level, critical proteins influence the host's interaction with pathogens like Candida. The LRP3 gene encodes LDL receptor related protein 3, a biomolecule primarily involved in the internalization of lipophilic molecules into cells. [1] This cellular function, while not fully elucidated in the context of candidiasis, suggests a potential role in cellular uptake processes that could be relevant to fungal interaction or nutrient sensing. In parallel, WDR88 represents another protein whose genetically predicted increased expression is associated with an elevated risk of candidiasis. [1] While the precise cellular functions and molecular pathways of WDR88 are still under investigation, its consistent association across multiple tissues points to its significance as a key biomolecule in the host's response to or susceptibility to candidal infection.
Tissue-Level Pathology and Systemic Impact
Candidiasis can manifest in various tissues and organs, and genetic factors contribute to this diverse presentation. Genetically predicted increased expression of LRP3 has been significantly associated with an elevated risk of candidiasis in a wide array of tissues, including the esophagus mucosa, brain spinal cord cervical, artery, spleen, prostate, adrenal gland, and minor salivary gland. [1] The association with esophageal mucosa is particularly notable given that the esophagus is a well-recognized site for Candida infection, reflecting specific tissue interactions in disease development. [1] Similarly, increased expression of WDR88 has been linked to candidiasis risk in the liver, brain cortex, heart atrial appendage, and skin. [1] The consistent replication of these genetic associations across multiple tissues suggests that the underlying pathophysiological processes may involve systemic mechanisms, indicating that candidiasis susceptibility is not limited to a single organ but can have widespread consequences throughout the body.
Host Immune Response and Broader Genetic Influences
Host genetic variation plays a critical role in an individual's overall susceptibility to infections, including candidiasis. More than 300 rare Mendelian disorders, often resulting from mutations in genes regulating immune responses, predispose individuals to various infections. [1] This highlights the fundamental importance of a robust and genetically sound immune system in infection defense. While the HLA region is generally recognized as critical for the host's response to infection, specific direct associations with candidiasis in this context include an association between rs600038 in the ABO gene region and candidiasis risk. [1] These findings collectively emphasize that a complex interplay of genetic factors, influencing both specific cellular pathways and broader immune functions, contributes to an individual's homeostatic balance and their ability to resist or succumb to candidal infections.
Host Receptor-Mediated Interactions and Cellular Uptake
The host's susceptibility to candidiasis can be influenced by specific molecular pathways involved in cellular interactions and uptake. The LDL receptor-related protein 3 (LRP3) is implicated in the internalization of lipophilic molecules, a fundamental cellular process that could potentially mediate host-pathogen interactions or nutrient availability relevant to infection. [1] Studies have found that genetically predicted increased expression of LRP3 is significantly associated with an elevated risk of candidiasis across various tissues, including esophageal mucosa, brain spinal cord cervical, artery, spleen, prostate, adrenal gland, and minor salivary gland. [1] While the precise mechanisms linking LRP3's role in lipophilic molecule internalization to altered candidiasis risk are not fully elucidated, this association suggests a pathway involving receptor function and cellular uptake in the host response.
Genetic Regulation of Host Defense
Host defense against candidiasis is intricately tied to the genetic regulation of specific proteins, where variations in gene expression can alter disease risk. Genetically predicted increased expression of WDR88 has been significantly associated with an elevated risk of candidiasis, with this association consistently observed in tissues such as the liver and brain cortex. [1] Although the specific function of WDR88 remains largely unclear, its recurrent association with candidiasis risk across multiple tissues suggests a fundamental, albeit undefined, role in the host's ability to combat Candida infection. [1] These findings underscore that gene regulation, by influencing the levels of proteins like LRP3 and WDR88, represents a critical regulatory mechanism impacting an individual's susceptibility to candidiasis.
Immune System Modulation and ABO Blood Group
The host immune response and specific genetic loci, including those governing blood group antigens, are crucial in mediating susceptibility to candidiasis. An association has been identified between rs600038 in the ABO gene region and the risk of candidiasis, indicating a potential role for ABO blood group antigens in modulating the host's interaction with the pathogen. [1] Furthermore, the HLA (Human Leukocyte Antigen) region is widely recognized as critical for the host's overall immune response to infection, highlighting the importance of genetic variants within immune system components in determining infection outcomes. [1] These genetic associations suggest that intrinsic host factors, encompassing aspects of immune recognition and cellular surface properties, contribute significantly to an individual's vulnerability to candidiasis.
Multi-Tissue Systemic Responses
The systemic nature of candidiasis susceptibility is highlighted by the observation that genetic associations with the infection are replicated across diverse host tissues. The genetically predicted expression of both LRP3 and WDR88 demonstrates significant associations with candidiasis risk in multiple tissues throughout the body. [1] This widespread tissue involvement suggests that the underlying mechanisms influencing candidiasis risk are not confined to a single organ but rather represent common, system-level responses or vulnerabilities that manifest across various physiological contexts. [1] Such multi-tissue associations imply a complex interplay of pathways that contribute to an emergent susceptibility phenotype, underscoring the integrated nature of host defense against Candida.
Genetic Modulators of Candidiasis Risk
Genetic variations within the host significantly influence an individual's susceptibility to candidiasis, thereby impacting the overall disease course and the potential necessity for therapeutic interventions. For instance, a variant in the WDR88 gene, rs10422015 (T allele), has been identified as being associated with an increased risk of candidiasis. [1] Further studies indicate that genetically predicted increased expression of WDR88 in tissues such as the liver and brain cortex is linked to a higher risk of developing candidiasis. [1] While the precise molecular mechanisms by which WDR88 influences candidiasis pathogenesis are not fully understood, its association suggests a role in host defense or immune signaling pathways that could affect the body's ability to control Candida infections, making it a host factor influencing disease susceptibility. Additionally, the rs600038 variant in the ABO gene region has also been associated with candidiasis, pointing to the potential involvement of blood group antigens or related host factors in modulating susceptibility to this fungal infection. [1]
LRP3 and Potential Pharmacodynamic Considerations
The LRP3 gene, encoding LDL receptor related protein 3, represents another genetic factor associated with candidiasis risk that may have broader pharmacodynamic implications. Genetically predicted increased expression of LRP3 in various tissues, including esophageal mucosa, brain spinal cord cervical, artery, spleen, prostate, adrenal gland, and minor salivary gland, is significantly associated with an elevated risk of candidiasis. [1] Mechanistically, LRP3 is known to be involved in the internalization of lipophilic molecules. [1] While current research primarily links LRP3 expression to candidiasis risk, its role in cellular uptake could hypothetically influence the cellular availability or distribution of certain lipophilic antifungal compounds, thereby indirectly affecting their pharmacodynamic action within infected tissues. Further investigation is warranted to explore how genetic variations in LRP3 might modulate the efficacy or adverse reaction profile of antifungal therapies.
Clinical Implementation and Personalized Management Strategies
Understanding the genetic predisposition to candidiasis, as evidenced by variants in genes like WDR88, LRP3, and ABO, holds promise for developing more personalized management strategies. Identifying individuals at higher genetic risk could facilitate targeted preventative measures or earlier diagnostic interventions, potentially reducing disease burden. [1] While specific pharmacogenomic guidelines for antifungal agents in candidiasis, such as dosing recommendations based on these particular risk variants, are not yet established, the broader field of pharmacogenetics is advancing rapidly.
The development of pharmacogenomic phenotypes for various genes, including cytochrome P450 enzymes like CYP2B6, CYP2C19, CYP2C9, CYP3A5, CYP4F2, and drug transporters such as SLCO1B1, is guided by established frameworks like the Clinical Pharmacogenetics Implementation Consortium (CPIC). [2] These guidelines, while not currently applied to candidiasis treatment in the provided context, illustrate the potential for future personalized prescribing in infectious diseases. As research progresses, integrating genetic risk profiles with pharmacogenetic data on drug metabolism, distribution, and targets could lead to more refined drug selection and dosing strategies for candidiasis patients, optimizing therapeutic response and minimizing adverse reactions.
Frequently Asked Questions About Candidiasis
These questions address the most important and specific aspects of candidiasis based on current genetic research.
1. Why do I get yeast infections more than my friends?
Your genetic makeup plays a significant role in how susceptible you are to candidiasis. Research shows that inherited factors contribute highly to how your body responds to pathogens like Candida. Specific genes, such as WDR88 and LRP3, have been linked to an altered risk, meaning some people are genetically more predisposed to these infections than others.
2. Does my family history mean I'll definitely get candidiasis?
While host genetic factors are crucial and highly heritable, a family history doesn't guarantee you'll get candidiasis. Your genes influence your susceptibility, but environmental factors, lifestyle, and your immune system's current state also play a big part. Understanding your genetic predisposition can help you take preventive measures.
3. Can I change my habits to reduce my personal risk?
Absolutely. While your genes influence susceptibility, lifestyle and environmental factors are also very important. Maintaining a healthy immune system, managing chronic conditions, and avoiding disruptions to your normal microbial flora can help reduce your risk. Genetic predisposition means you might be more prone, but it doesn't mean you can't influence your risk.
4. I'm getting older; does that increase my chance of infection?
Yes, the average age of individuals diagnosed with candidiasis is around 51.2 years, suggesting its prevalence across adult populations. While genetics are a constant factor, age often brings changes in immune function or other health conditions that can make you more vulnerable to opportunistic infections like candidiasis, even if you have a genetic predisposition.
5. Is a genetic test useful to understand my candidiasis risk?
A genetic test could provide insights into your individual susceptibility by identifying specific gene regions linked to candidiasis risk, like WDR88 or LRP3. For example, having the T allele of rs10422015 in WDR88 is associated with an increased risk. This information can help you and your doctor understand your predisposition and potentially guide preventive strategies.
6. Does my ethnic background affect my susceptibility?
Research suggests that genetic risk factors can vary across different populations. Studies on candidiasis have primarily been conducted in White patients, meaning the findings might not fully apply to other ethnic groups due to differences in genetic architecture. More diverse research is needed to understand specific susceptibilities across all backgrounds.
7. Why do some people never seem to get oral thrush?
Your genetic makeup significantly influences your body's ability to resist Candida overgrowth. Some individuals possess genetic variations that make them less susceptible, such as different patterns in genes like WDR88 or LRP3. Their immune system or natural microbial balance might also be more robust, preventing the fungus from causing infection.
8. Does stress or my environment make me more prone to it?
Environmental and social factors are known to influence infection susceptibility, although current genetic studies often don't fully account for them. While your genes set a baseline for risk, high stress levels or certain environmental exposures can weaken your immune system or disrupt your body's microbial balance, potentially tipping the scales towards an infection.
9. If my immune system is weak, is that due to my genes?
Your immune system's strength is a complex trait influenced by both genetics and environmental factors. While some genetic variations can predispose you to a weaker immune response, factors like nutrition, stress, other illnesses, and medications also play a significant role. Genes like WDR88 and LRP3 influence your susceptibility to Candida, which is tied to immune function.
10. Can what I eat influence my risk of these infections?
While specific dietary impacts aren't directly detailed in current genetic studies, your diet can influence your overall health, immune system, and gut microbiome, which are all crucial in preventing Candida overgrowth. A balanced diet supports a healthy immune system and microbial flora, helping your body keep Candida in check, even if you have a genetic predisposition.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
[1] Jiang L, et al. "Genome-wide association analyses of common infections in a large practice-based biobank." BMC Genomics, vol. 23, no. 1, 2022, p. 672.
[2] Liu, T. Y. et al. "Diversity and longitudinal records: Genetic architecture of disease associations and polygenic risk in the Taiwanese Han population." Sci Adv, vol. 10, no. 19, 2024, p. eadj9007.
[3] Visscher PM, et al. "Meta-analysis of the heritability of human traits based on fifty years of twin studies." Nature Genetics, vol. 47, no. 7, 2015, pp. 702-09.